| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Temozolomide plus thalidomide in patients with brain metastases from melanoma: a phase II study. | Cancer | 2005 | 1.13 |
| 2 | Phase II study of temozolomide plus pegylated interferon-alpha-2b for metastatic melanoma. | Cancer | 2006 | 0.91 |